M-TRANYLCYPROMINE DIN 02542188
Status: Marketed
Holder: MANTRA PHARMA INC
Health Canada record
| Active ingredient(s) | TRANYLCYPROMINE (TRANYLCYPROMINE SULFATE) 10 MG |
|---|
| Dosage form | Tablet |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | N06AF04 TRANYLCYPROMINE |
|---|
| Original market date | 07-Mar-2025 |
|---|
| Current status date | 07-Mar-2025 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Mantra Pharma Inc. — licence 101740, currently licensed, last inspection rating C (2023-05-10).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TRANYLCYPROMINE (TRANYLCYPROMINE SULFATE)
| DIN | Product | Company | Form | Strength | Status |
|---|
| 01919598 | PARNATE | GLAXOSMITHKLINE INC | Tablet | TRANYLCYPROMINE (TRANYLCYPROMINE SULFATE) 10 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 31815 | 2023-10-11 | Abbreviated New Drug Submission (ANDS) | |
Request a quote for M-TRANYLCYPROMINE
How to read a Canadian DIN record